I had the pleasure of speaking recently with Dr. Serena Chen and Steve Hsu about PGT-P. 

I wanted to chat about PGT-P specifically because it has recently been the focus of quite a bit of media attention. PGT-P is a genetic test specifically designed to screen polygenic, or “many gene” disorders. 

This episode covers what PGT-P is and why there has been so much media attention surrounding it. As always, my goal is for the listener to come away with a baseline understanding of the technology so that they can make informed decisions throughout their fertility journey. 

Meet the guests: 

Dr. Serena Chen: IVF DIRECTOR AT IRMS

Dr. Chen serves as Director for the Division of Reproductive Medicine in the Department of Obstetrics and Gynecology at Saint Barnabas Medical Center, and the Institute for Reproductive Medicine and Science. Dr. Chen is widely recognized as a public advocate for education, reproductive rights, and access to reproductive care for all. SCIENTIFIC ADVISORY BOARD MEMBER, GENOMIC PREDICTION.

Prof. Stephen Hsu: FOUNDER, GENOMIC PREDICTION

Dr. Stephen Hsu is Professor of Theoretical Physics at Michigan State University. Educated at Caltech and Berkeley, he was a Harvard Junior Fellow and held faculty positions at Yale and the University of Oregon. Hsu was founder and CEO of SafeWeb, a Silicon Valley technology startup acquired by Symantec for $26 million. He is a scientific advisor to BGI and a member of its Cognitive Genomics lab.